두개내 동맥류 시장 규모는 2023년 11억 3,000만 달러에서 2024-2030년의 예측 기간 중 CAGR 9.10%로 추이하며, 2030년에는 19억 달러에 달할 것으로 예측됩니다.
두개내 동맥류 시장은 고혈압 등 만성질환 증가, 주요 기업의 혁신적인 제품 개발 활동, 노령 인구 증가, 정부 구상 증가 등에 힘입어 큰 폭 시장 성장세를 보이고 있습니다.
두개내 동맥류 시장 역학 :
세계보건기구(WHO)의 2023년 자료에 따르면 전 세계 30세에서 79세 사이의 성인 중 약 12억 8,000만 명이 중저소득 국가에 거주하는 것으로 추산됩니다. 고혈압은 두개내 동맥류 발생의 중요한 위험 요인으로 효과적인 진단 및 치료 옵션에 대한 수요가 증가하고 있으며, 이에 따라 두개내 동맥류 치료 관련 의료기기 및 기술 시장이 확대되고 있습니다.
WHO의 2021년 자료에 따르면 2015-2050년 60세 이상 노인 인구는 12%에서 22%로 두 배로 증가하며 2050년에는 21억 명에 달할 것으로 예측됩니다. 또한 2030년에는 6명 중 1명이 60세 이상이 될 것이라고 합니다. 두개내 동맥류로 이어질 수 있는 뇌혈관 질환과 같은 노화 관련 건강 문제의 유병률이 높아져 첨단 진단 및 치료 옵션이 필요하게 될 것입니다. 이러한 인구통계학적 변화로 인해 동맥류를 효과적으로 관리할 수 있는 혈관내 치료 및 기술에 대한 의료시스템의 투자가 증가하면서 동맥류 시장이 확대되고 있습니다.
두개내 동맥류 제품 유형별로는 색전 코일 부문이 2023년 큰 매출 점유율을 차지할 것으로 예상됩니다. 이는 색전술 코일이 널리 사용되고 있으며, 유용성과 효능을 높이는 다양한 주요 기능이 있기 때문입니다.
색전술 코일은 두개내 동맥류의 최소침습적 치료에서 중요한 역할을 하며, 동맥류 내로의 정확한 삽입을 보장하기 위해 높은 유연성과 X-선 투시성과 같은 주요 기능을 제공합니다. 일반적으로 백금으로 만들어진 이 코일은 동맥류 주머니를 채우도록 확장되어 혈전 형성을 유도하여 파열 위험을 줄입니다. 일부 코일은 동맥류 내부의 응고 및 치유를 촉진하기 위해 생물학적 활성 물질 또는 하이드로겔 물질로 코팅되어 있습니다.
지역별로는 북미가 2023년 시장을 주도할 것으로 예상되며, 예측 기간 중에도 비슷한 위치를 차지할 것으로 예상됩니다. 높은 뇌동맥류 발생률, 제품 개발 및 규제 당국의 승인, 시장내 주요 기업의 존재, 첨단 의료 인프라의 가용성 등 여러 요인이 예측 기간 중 이 지역의 성장에 기여할 것으로 예상됩니다.
세계의 두개내 동맥류 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 법규제 환경, 시장 규모 추이·예측, 각종 구분·지역/주요 국가별 상세 분석, 경쟁 구도, 주요 기업의 개요 등을 정리하여 전해드립니다.
Intracranial Aneurysms Market by Product Type (Surgical Clipping, Embolization Coils, Flow Diverters, and Others), End-User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a respectable CAGR forecast till 2030 owing to the increasing cases of chronic disorders and the rising product developmental activities worldwide
The intracranial aneurysms market was valued at USD 1.13 billion in 2023, growing at a CAGR of 9.10% during the forecast period from 2024 to 2030, to reach USD 1.90 billion by 2030. The intracranial aneurysms market is observing substantial market growth primarily owing to the increasing cases of chronic disorders such as hypertension, innovative product developmental activities by leading companies, expanding geriatric population, and increasing government initiatives that are factors expected to escalate the overall growth of the intracranial aneurysms market during the forecast period from 2024 to 2030.
Intracranial Aneurysms Market Dynamics:
As per data provided by the World Health Organization (WHO) (2023), it stated that an estimated 1.28 billion adults aged between 30 and 79 years worldwide had hypertension, living in low- and middle-income countries. High blood pressure or hypertension is a significant risk factor for intracranial aneurysms, leading to an increased demand for effective diagnostic and treatment options and thus resulting in a larger market for medical devices and technologies related to intracranial aneurysm treatment.
Data from the WHO 2021, stated that between 2015 and 2050, people falling between 60 years and above will be doubled from 12 to 22%, and will eventually reach 2.1 billion by the year 2050, globally. Moreover, by 2030, 1 in 6 people will age 60 years or above. Due to the higher prevalence of age-related health issues, including cerebrovascular diseases that can lead to intracranial aneurysms, necessitating advanced diagnostic and treatment options. This demographic shift is prompting healthcare systems to invest more in endovascular procedures and technologies to manage aneurysms effectively, thereby expanding the market for same.
Increased product developmental activities by market players worldwide is also slated to witness market growth for intracranial aneurysms. For example, in June 2022, Medtronic announced the launch of CE marked fourth-generation flow diverter, Pipeline Vantage with Shield Technology for endovascular treatment of brain aneurysms.
Additionally, in September 2023, The Brain Aneurysm Foundation announced the launch of 'Stop the Pop', a new campaign intended to increase awareness of the prevalence and impact of brain aneurysms, and the need for ongoing investment to fund new innovations, screening, and treatment.
Therefore, all the factors stated above collectively will drive the overall intracranial aneurysms market growth.
However, stringent regulatory approval processes, complications associated with intracranial aneurysm treatment devices, and others may prove to be challenging factors for the intracranial aneurysms market growth.
Intracranial Aneurysms Market Segment Analysis:
Intracranial Aneurysms Market by Product Type (Surgical Clipping, Embolization Coils, Flow Diverters, and Others), End-User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the product type segment of intracranial aneurysms, the embolization coils category is expected to have a significant revenue share in the year 2023. This is because of the widespread uses and various key features of embolization coils that enhance their utility and effectiveness.
Embolization coils are critical in the minimally invasive treatment of intracranial aneurysms, offering key features such as high flexibility and visibility under X-ray, which ensure precise placement within the aneurysm. Typically made of platinum, these coils expand to fill the aneurysm sac, inducing clot formation and reducing the risk of rupture. Some coils are coated with bioactive or hydrogel materials to enhance clotting and healing within the aneurysm.
Embolization coils are primarily used for aneurysm occlusion, preventing blood flow into the aneurysm to reduce rupture risk. These are effective for small saccular and wide-necked aneurysms, and in complex cases, they may be used with adjunctive devices like stents or flow diverters to enhance treatment outcomes.
Furthermore, companies raising funds for the development and commercialization of the development of embolic coils are also expected to contribute to the segmental growth of the intracranial aneurysm market. For instance, in July 2021, a neuro- and peripheral-vascular interventional medical device company, Zylox-Tonbridge Medical Technology Co., Ltd. raised USD 329 million to aid the development and commercialization of its core products that include neurovascular embolization coils, a microcatheter for coiling, and others.
Therefore, the widespread uses and various key features of embolization coils that enhance performance and usability are solidifying the impact on the growth of the overall intracranial aneurysms market during the forecast period from 2024 to 2030.
North America is expected to dominate the overall intracranial aneurysms market:
Among all the regions, North America is expected to dominate the intracranial aneurysms market in the year 2023 and is expected to do the same during the forecast period. This can be attributed to several factors including the high instances of brain aneurysm, combined with significant advancements in product development & regulatory approvals, presence of market key players, and availability of well-established advanced healthcare infrastructure that are acting as key factors contributing to the growth of the intracranial aneurysms market in the North America region during the forecast period from 2024 to 2030.
According to recent updated data from the Brain Aneurysm Foundation, stated that currently approximately 6.8 million individuals are affected by the brain aneurysm in the US. Further it added that, about 30,000 people in the US suffers brain aneurysm rupture each year. This condition is more prevalent in the individuals of aged from 35 to 60.
Since the cases of brain aneurysms is rising among middle-aged individuals the demand for more effective diagnostic and treatment options is increasing significantly. This trend is fueling investment in innovative technologies and expanding the market for the intracranial aneurysms.
Rising product developmental activities by market players in the region will further boost the market for intracranial aneurysms. For example, in June 2024, subsidiary of Terumo Corporation (Micro Vention), announced the US launch for its LVIS EVO intraluminal support device. The device is available in the US for the treatment of wide-neck intracranial aneurysms.
The prompt and well-established healthcare services and infrastructure further contribute to the growth of the regional intracranial aneurysms market growth. The presence of key players such as Johnson & Johnson Services, Inc., Medtronic, and Boston Scientific Corporation with their strong distribution networks ensure widespread availability and accessibility of these devices across the region increasing their revenue shares in the market, and supportive reimbursement programs providing immense growth opportunities for the same.
Therefore, the interplay of all the aforementioned factors would provide a conducive growth environment for the North American intracranial aneurysms market.
Intracranial Aneurysms Market key players:
Some of the key market players operating in the intracranial aneurysms market include Medtronic, MicroPort Scientific Corporation., B. Braun Melsungen AG, Stryker, Johnson & Johnson Services, Inc., Terumo Corporation, Penumbra, Inc., Balt, Wallaby Medical, Shape Memory Medical Inc, Zylox-Tonbridge Medical Technology Co., Ltd., Spartan Micro, Inc., Mizuho Medical Co.Ltd, Lepu Medical Technology Co., Ltd., Phenox GmbH, Peter LAZIC GmbH, adeor medical AG, Boston Scientific Corporation, Meril Life Sciences Pvt. Ltd, KANEKA CORPORATION, and others.
Recent Developmental Activities in the Intracranial Aneurysms Market:
Key Takeaways from the Intracranial Aneurysms Market Report Study
Target Audience who can be benefited from this Intracranial Aneurysms Market Report Study
Frequently Asked Questions for the Intracranial Aneurysms Market:
North America is expected to dominate the overall intracranial aneurysms market during the forecast period from 2024 to 2030. This can be attributed to several factors including the high instances of brain aneurysm, combined with significant advancements in product development & regulatory approvals, presence of market key players, and availability of well-established advanced healthcare infrastructure that are acting as key factors contributing to the growth of the intracranial aneurysms market in the North America region during the forecast period from 2024 to 2030.